July 01, 2020 – PRMS

The iRIS WIKI has the following updates to the Study Team Section...

April 20, 2020 – PRMS

A PowerPoint training will be presented for the first half, followed by the opportunity for attendees to submit questions to the panelists in a live Q&A.

January 28, 2020 – PRMS

We wanted to provide an update on the Dana Farber / Harvard Cancer Center clinical trial support system. As you know, over the summer, we launched iRIS, an online submission and review system.

January 10, 2020 – PRMS

Please review the following tips and tricks that the iRIS team has gathered to help you to interact with the system better.

January 10, 2020 – PRMS

The application for Secondary Use, Medical Record Review, and Non-Human Subject Research Determination have been simplified to include only the regulatory questions needed for such submissions and no longer require a...

January 10, 2020 – PRMS

A new operational form, Sponsor- Investigator Add External Site Form, has been added to the General Forms section of the study management page. This form is to be utilized for Investigator-Sponsored, Multi-Center...

January 10, 2020 – PRMS

In previous workflows for new trials and applicable amendment submissions, pharmacy and nursing had two separate reviews: Pre-SRC and Feasibility. These reviews have been combined.

January 10, 2020 – PRMS

The process for attestation forms has been updated. Please note this is an operational form to assist the study team in tracking that COI is appropriately reported to the IRB per study, as applicable. All attestation...

January 10, 2020 – PRMS

Per several requests, we have modified the way outcome letters and activation emails are handled.

January 10, 2020 – PRMS

In an effort to increase transparency within iRIS, there has been an update to the Reviewer Details and Comments by Reviewers on Submissions. This report includes the review and sign-off only committee(s) your submission...